Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 5.51% vs 18.69% in Jun 2025
Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is 136.36% vs -33.33% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 62.26% vs 17.78% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Sandu Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 5.51% vs 18.69% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -0.45% vs 6.56% in Sep 2024
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is 136.36% vs -33.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 4.00% vs -9.09% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 62.26% vs 17.78% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -5.49% vs 9.64% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 200.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






